Tavo Biotherapeutics | RoundOS

Weekly digest by email

Loading companies…

Tavo Biotherapeutics | RoundOS

Weekly digest by email

Funding history

1 round · 1 with disclosed amounts

Announced	Round	Amount	Investors
Jun 2, 2026	Series A	$17M	Polaris Partners — Role not disclosedPureos Bioventures — Role not disclosedTau Capital — Role not disclosed

Investors

Polaris PartnersSeries A Pureos BioventuresSeries A Tau CapitalSeries A

Coverage

Jun 2, 2026Tavo Biotherapeutics · Series A

Similar companies

AusperBioDevelops oligonucleotide therapeutics targeting chronic hepatitis B$120M · Series C

MetriportOpen-source healthcare data infrastructure unifying patient records for clinicians$26M · Series A

ProFound TherapeuticsUses AI and proteomics to discover drug targets and biomarkers for preeclampsia and eclampsia$35M · Strategic

Sources

tavobio.com ↗